Validation of a novel automated system, Fluispotter®, for serial sampling of dried blood spots.
automated sampling
cortisol
diurnal
dried blood spots
Journal
Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
received:
12
03
2023
accepted:
20
03
2023
medline:
21
3
2023
pubmed:
21
3
2023
entrez:
20
3
2023
Statut:
epublish
Résumé
Repeated blood sampling is required in certain clinical and research settings, which is currently performed by drawing blood from venous catheters requiring manual handling of each sample at the time of collection. A novel body-worn device for repeated serial samples, Fluispotter®, with automated extraction, collection, and storage of up to 20 venous dried blood spot samples over the course of 20 h may overcome problems with current methods for serial sampling. The purpose of this study was to assess the performance and safety of Fluispotter for the first time in healthy subjects. Fluispotter consists of a cartridge with tubing, a reservoir for flushing solution, pumps and filterpaper, and a multi-lumen catheter placed in the brachial vein. We recruited healthy subjects for testing in an in-hospital setting. Fluispotter was attached by an anesthesiologist to 22 healthy subjects of which 9/22 (40.9%) participants had all 20 samples taken, which was lower than the goal of complete sampling in 80% of the subjects (P = 0.02). The main reason for sample failure was clogging of blood flow which was observed in 11/22 (50%) of the participants. No serious adverse events occurred, and the participants rated the pain from the insertion and the removal of catheter as very low. A cortisol profile showed nadir values at midnight and highest values at 05:00 h. Although full sampling was not successful in all participants, the Fluispotter technology proved safe and highly acceptable to the participants producing the expected cortisol profile without the requirement of staff during sample collection.
Identifiants
pubmed: 36939600
doi: 10.1530/EC-23-0087
pii: EC-23-0087
pmc: PMC10305485
doi:
pii:
Types de publication
Journal Article
Langues
eng
Références
Mass Spectrom Rev. 2016 May-Jun;35(3):361-438
pubmed: 25252132
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
Chronobiol Int. 2016;33(8):1101-19
pubmed: 27308960
Anaesthesia. 2012 Jan;67(1):65-71
pubmed: 21972789
Bioanalysis. 2020 May;12(10):665-681
pubmed: 32489105
EBioMedicine. 2016 Sep;11:285-295
pubmed: 27543154
J Pharmacol Toxicol Methods. 2022 Mar-Apr;114:107155
pubmed: 35038558
J Clin Endocrinol Metab. 2016 Feb;101(2):364-89
pubmed: 26760044
J Pharm Biomed Anal. 2016 Oct 25;130:231-243
pubmed: 27390013
PLoS One. 2020 Sep 28;15(9):e0239675
pubmed: 32987398
J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
pubmed: 21602453
J Clin Endocrinol Metab. 2007 Apr;92(4):1326-33
pubmed: 17244781
Intern Med. 2021;60(5):699-707
pubmed: 33642560
Rev Med Virol. 2022 Jul;32(4):e2320
pubmed: 34957630
J Med Eng Technol. 2013 Apr;37(3):180-4
pubmed: 23547774
Ther Drug Monit. 2021 Jun 1;43(3):346-350
pubmed: 33973966
Pharm Res. 2021 May;38(5):759-778
pubmed: 33846903
Br J Health Psychol. 2019 Nov;24(4):806-827
pubmed: 31250487